|
WO2020036938A2
|
|
Compositions for ovarian cancer assessment
|
|
US2015153348A1
|
|
BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN
|
|
US2015126384A1
|
|
Prognostic Biomarkers in Patients with Ovarian Cancer
|
|
US2013267439A1
|
|
Predictive markers and biomarker panels for ovarian cancer
|
|
US2013073308A1
|
|
Methods of Detecting a Fragment of Neurosecretory Protein VGF for Diagnosing Alzheimer's Disease
|
|
KR20140024860A
|
|
Biomarker panels, diagnostic methods and test kits for ovarian cancer
|
|
AU2011316844A1
|
|
Prognostic biomarkers in patients with ovarian cancer
|
|
EP2220506A2
|
|
Biomarkers for the detection of early stage ovarian cancer
|
|
US2008274481A1
|
|
Methods for diagnosing ovarian cancer
|
|
EP2210099A1
|
|
Biomarkers for ovarian cancer
|
|
WO2008057966A2
|
|
A panel of biomarkers for peripheral arterial disease
|
|
WO2008057806A1
|
|
A panel of biomarkers for peripheral arterial disease
|
|
WO2008048508A2
|
|
Prognostic biomarkers in patients with ovarian cancer
|
|
WO2007133957A1
|
|
Biomarkers for mesothelioma: apoc1 and apoa2
|
|
US2010173788A1
|
|
Biomarkers for breast cancer
|
|
EP1907838A2
|
|
Fragment of neurosecretory protein vgf as a biomarker for alzheimer's disease
|
|
EP1877416A2
|
|
Saposin d and fam3c are biomarkers for alzheimer's disease
|
